Jon V. Warkentin - Publications

TB-free Ebeye: Results from integrated TB and noncommunicable disease case finding in Ebeye, Marshall Islands.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases

Published: February 15, 2024

Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: February 28, 2023

Tuberculosis Screening, Testing, and Treatment of US Health Care Personnel: ACOEM and NTCA Joint Task Force on Implementation of the 2019 MMWR Recommendations.

Journal: Journal of occupational and environmental medicine

Published: July 31, 2020

Gaps in the care cascade for screening and treatment of refugees with tuberculosis infection in Middle Tennessee: a retrospective cohort study.

Journal: BMC infectious diseases

Published: October 31, 2019

Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 30, 2019

Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities.

Journal: Annals of the American Thoracic Society

Published: March 01, 2018

A comparison of interview methods to ascertain fluoroquinolone exposure before tuberculosis diagnosis.

Journal: Epidemiology and infection

Published: November 26, 2014

Tuberculosis and the risk of infection with other intracellular bacteria: a population-based study.

Journal: Epidemiology and infection

Published: August 23, 2014

Non-adherence and drug-related interruptions are risk factors for delays in completion of treatment for tuberculosis.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: February 12, 2013

Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones.

Journal: International journal of antimicrobial agents

Published: January 31, 2013

Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: July 17, 2012

High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.

Journal: Journal of clinical microbiology

Published: December 23, 2011